Skip to main content
Log in

Phenytoin not cost effective for status epilepticus

  • Clinical study
  • Published:
PharmacoEconomics & Outcomes News

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Notes

  1. 2018 US dollars

Reference

  • Sanchez Fernandez I, et al. Meta-analysis and cost-effectiveness of second-line antiepileptic drugs for status epilepticus. Neurology : 8 May 2019

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Phenytoin not cost effective for status epilepticus. PharmacoEcon Outcomes News 829, 19 (2019). https://doi.org/10.1007/s40274-019-5933-3

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40274-019-5933-3

Navigation